- Home
- TIRX vs APVO Comparison
TIRX vs APVO Comparison
Compare TIRX & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIRX
- APVO
- Stock Information
- Founded
- TIRX 2010
- APVO 2016
- Country
- TIRX China
- APVO United States
- Employees
- TIRX N/A
- APVO N/A
- Industry
- TIRX Specialty Insurers
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- TIRX Finance
- APVO Health Care
- Exchange
- TIRX Nasdaq
- APVO Nasdaq
- Market Cap
- TIRX 4.6M
- APVO 3.7M
- IPO Year
- TIRX 2021
- APVO N/A
- Fundamental
- Price
- TIRX $1.64
- APVO $0.21
- Analyst Decision
- TIRX
- APVO Strong Buy
- Analyst Count
- TIRX 0
- APVO 1
- Target Price
- TIRX N/A
- APVO $8.00
- AVG Volume (30 Days)
- TIRX 35.9K
- APVO 17.5M
- Earning Date
- TIRX 08-16-2024
- APVO 11-07-2024
- Dividend Yield
- TIRX N/A
- APVO N/A
- EPS Growth
- TIRX N/A
- APVO N/A
- EPS
- TIRX N/A
- APVO N/A
- Revenue
- TIRX $697,733.00
- APVO N/A
- Revenue This Year
- TIRX N/A
- APVO N/A
- Revenue Next Year
- TIRX N/A
- APVO N/A
- P/E Ratio
- TIRX N/A
- APVO N/A
- Revenue Growth
- TIRX N/A
- APVO N/A
- 52 Week Low
- TIRX $1.53
- APVO $0.14
- 52 Week High
- TIRX $7.40
- APVO $10.80
- Technical
- Relative Strength Index (RSI)
- TIRX 40.39
- APVO 43.68
- Support Level
- TIRX $1.60
- APVO $0.24
- Resistance Level
- TIRX $1.85
- APVO $0.33
- Average True Range (ATR)
- TIRX 0.12
- APVO 0.04
- MACD
- TIRX -0.03
- APVO -0.01
- Stochastic Oscillator
- TIRX 7.24
- APVO 0.70
About TIRX TIAN RUIXIANG Holdings Ltd
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.